The market hasn't yet comprehended the immense val
Post# of 36728
Posted On: 10/22/2013 2:21:36 PM
The market hasn't yet comprehended the immense value of what SK is holding in Dharmanol. The best Big Pharma cancer treatment drugs are now so expensive and their effect so short-lived that doctors are reluctant to prescribe them. Meanwhile, in the past 10 years, cancer has claimed over six million lives, many of them were breadwinners or caretakers of families with many years still left to live. The cost to their families and to society as a whole is staggering, not just in medical costs which can run over $100,000 or more per year.
Into this crisis steps Dharmanol, The Miracle in a Tablet or Lozenge, an all-natural "nutritional supplement" that needs no FDA approval. And, yet, from various accounts, it may beat the pants off Big Pharma compounds. That realization will hit the market like a ton of brick.
Into this crisis steps Dharmanol, The Miracle in a Tablet or Lozenge, an all-natural "nutritional supplement" that needs no FDA approval. And, yet, from various accounts, it may beat the pants off Big Pharma compounds. That realization will hit the market like a ton of brick.
(0)
(0)SK3 Group Inc. (SKTO) Stock Research Links
Scroll down for more posts ▼